Tibolone

CAS No. 5630-53-5

Tibolone( Tibolone | Xyvion | Tibolonum )

Catalog No. M18813 CAS No. 5630-53-5

Tibolone is an estrogen-like compound used for the treatment of the symptoms associated with menopausal transition (i.e., climacteric symptoms) and also for the treatment of osteoporosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tibolone
  • Note
    Research use only, not for human use.
  • Brief Description
    Tibolone is an estrogen-like compound used for the treatment of the symptoms associated with menopausal transition (i.e., climacteric symptoms) and also for the treatment of osteoporosis.
  • Description
    Tibolone is an estrogen-like compound used for the treatment of the symptoms associated with menopausal transition (i.e., climacteric symptoms) and also for the treatment of osteoporosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Tibolone | Xyvion | Tibolonum
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    ER
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5630-53-5
  • Formula Weight
    312.45
  • Molecular Formula
    C21H28O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]3(O)C#C)[C@H]12
  • Chemical Name
    19-Norpregn-5(10)-en-20-yn-3-one, 17-hydroxy-7-methyl-, (7alpha,17alpha)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kloosterboer HJ.etal.Tissue-selectivity: the mechanism of action of tibolone.Maturitas. 2004 Aug 30;48 Suppl 1:S30-40.
molnova catalog
related products
  • I-OMe-Tyrphostin AG ...

    I-OMe-Tyrphostin AG 538 is a specific IGF-1R inhibitor and ATP-competitive inhibitor of PI5P4Kα (IC50: 1 μM).

  • BAY 80-6946

    BAY 80-6946 (Copanlisib) is a potent and highly selective reversible PI3K inhibitor for PI3Kα/β with IC50 of 0.469 nM/3.72 nM. Phase 2.

  • GDC-0077

    GDC-0077 (RG-6114) is a potent, highly isoform selective inhibitor of PI3Kα, with IC50 of 0.038 nM.